Delirium Tied to Increased Risk of Death in Critically Ill With Cancer
Critically ill patients with cancer who develop delirium have a higher risk of dying in the hospital or intensive care unit, a study suggests.
Critically ill patients with cancer who develop delirium have a higher risk of dying in the hospital or intensive care unit, a study suggests.
Race and ethnicity are associated with delays or discontinuations of cancer treatment after COVID-19, but social determinants of health are not, a study suggests.
A team of investigators examined the financial burden of breast, lung, colorectal, and prostate cancers for nonelderly adults with private insurance.
Adjuvant pembrolizumab could be a new standard of care for patients with clear cell renal cell carcinoma at increased risk of recurrence after nephrectomy, according to researchers.
A new study suggests that previous use of cannabis is associated with a lower risk of certain genitourinary cancers.
Adding docetaxel to standard care improved failure-free survival and progression-free survival (PFS) but not overall survival, metastatic PFS, or prostate cancer-specific survival.
Some disparities that existed before FDA approval persisted after approval, and some new disparities emerged after FDA approval.
Increases in waist-to-hip ratio, body mass index, waist circumference, and total body fat percentage were associated with increases in the risk of prostate cancer death.
The median rPFS was 24.0 months in the apalutamide arm and 16.6 months in the placebo arm.
For patients hospitalized with COVID-19, prostate cancer was the most common cancer type across all databases.